POSTER SESSION V
Wednesday, March 21, 2012 — 9:30 AM - 12:00 Noon
CC Exhibit Hall B3 & C
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GENITOURINARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
82
Malignancies Arising in Allograft Kidneys
(1000)
R Saleeb, H Faragalla, K Sy, GM Yousef, R Stewart, CJ Streutker - University of Toronto, Toronto, ON, Canada; St. Michael´s Hospital, Toronto, ON, Canada
Hemangioma in Kidney with End-Stage Renal Disease: A Novel Association
(879)
SL Haley, ON Kryvenko, M Aron, SS Shen, JI Epstein, NS Gupta, M Amin, LD Truong - The Methodist Hospital, Houston, TX; Cornell University, New York, NY; Cedars Sinai Medical Center, Los Angeles, CA; Henry Ford Medical Center, Detroit, MI; The John Hopkins University, Baltimore, MD
Cytogenomic Molecular Profiles of Tubulocystic Carcinoma of the Kidney
(986)
G Quiroga-Garza, AG Ayala, L Truong, MB Amin, K Arora, I Alvarado-Cabrero, K Cuevas-Ocampo, FA Monzon - The Methodist Hospital Weil Medical College, Cornell University, Houston, TX; Cedars-Sinai Medical Center, Los Angeles, CA; Mexican Oncology Hospital, IMSS, Mexico City, DF, Mexico
Virtual Karyotype of Renal Carcinoid Tumors by SNP Microarrays
(782)
RW Allan, JA Jeung, D Cao, AV Parwani, LD Truong, FA Monzon - University of Florida College of Medicine, Gainesville, FL; Washington University School of Medicine, St. Louis, MO; University of Pittsburgh School of Medicine, Pittsburgh, PA; The Methodist Hospital Research Institute, Weill Cornell Medical College of Cornell University, Houston, TX
Primary Neuroendocrine Tumors of the Kidney. Morphological and Molecular Alterations of an Uncommon Malignancy
(792)
PP Aung, WM Linehan, CO Poropatich, MJ Merino - NCI/NIH, Bethesda, MD; Virginia Hospital Center, Arlington, VA
Multilocular Cystic Renal Cell Carcinoma: Similarities and Differences in Immunoprofile Compared to Clear Cell Renal Cell Carcinoma
(1058)
SR Williamson, S Halat, JN Eble, DJ Grignon, A Lopez- Beltran, R Montironi, PH Tan, M Wang, S Zhang, GT MacLennan, L Cheng - Indiana University School of Medicine, Indianapolis; Oschner Medical Center, New Orleans; Cordoba University, Cordoba, Spain; Polytechnic University of the Marche Region (Ancona), Ancona, Italy; Singapore General Hospital, Singapore; Case Western Reserve University, Cleveland
De-Differentiated Tubulocystic Carcinoma of the Kidney: A Series of 3 Cases with FISH Analysis
(781)
T Al-Hussain, L Cheng, S Zhang, JI Epstein - The Johns Hopkins Hospital, Baltimore; Indiana University School of Medicine, Indianapolis
Localized Cystic Disease of the Kidney Masquerading as Cystic Neoplasms
(1077)
M Zhou, L Chen, R Fan, S Bonsib - New York Universiy, New York, NY; Mayo Clinic Arizona, Scottsdale, AZ; Indiana University Medical School, Indianapolis, IN; Louisiana State University Health Sciences Center, Shreveport, LA
Fluorescence In Situ Hybridization (FISH) as an Adjunct Tool in the Diagnosis of Primary and Metastatic Renal Cell Carcinoma in Core Biopsy and Fine Needle Aspiration Biopsy Specimens
(922)
Z Kos, S Amin, EC Belanger, C Marginean, KT Mai - The Ottawa Hospital and University of Ottawa, Ottawa, ON, Canada
Relative Quantification of Protein Expression in Metastatic Clear Cell Renal Cell Carcinoma Tissue Using iTRAQ LC- MS/MS Analysis
(1056)
NMA White, O Masui, L DeSouza, O Krakovska, A Matta, KWM Siu, GM Yousef - St. Michael´s Hospital, Toronto, ON, Canada; York University, Toronto, ON, Canada
Extra-Renal Cancer Metastasizing to Primary Renal Neoplasms: A Rare Entity with Important Implications for Clinical Management
(990)
JP Reynolds, M Latour, J Zhang, XJ Yang, M Zhou - Cleveland Clinic, Cleveland, OH; CHUM, Montreal, QC, Canada; Mayo Clinic, Rochester, MN; Northwestern University, Chicago, IL
Multiplex Ligation-Dependent Probe Amplification (MLPA) Assay – A Novel Approach for Renal Tumor Typing
(1030)
M Tretiakova, P Reddy, T Antic, GP Paner, L Joseph - University of Chicago, Chicago
Histological Heterogeneity of Clear Cell Renal Cell Carcinoma (CCRCC). A Complete Morphological Analysis of 47 Tumors
(938)
JI Lopez, G Muniz, R Guarch, N Camarasa, M Caceres, V Moreno, L Garcia-Prats, R Orozco - Hospital de Cruces, Univ of the Basque Country (UPV/EHU), Barakaldo, Bizkaia, Spain; Hospital Virgen del Camino, Pamplona, Spain; Hospital Peset, Univ of Valencia, Spain; Hospital General Yagüe, Burgos, Spain; Hospital Txagorritxu, Vitoria-Gasteiz, Spain; Hospital San Jorge, Huesca, Spain; Hospital San Juan de Dios, Ciudad de Guatemala, Guatemala
Clear Cell Papillary Renal Cell Carcinoma in Von Hippel- Lindau Disease
(989)
P Rao, FA Monzon, E Jonasch, BA Czerniak, P Tamboli - MD Anderson Cancer Center, Houston, TX; Baylor College of Medicine, Houston, TX
Exploring the Role of miRNAs in Renal Cell Carcinoma Progression and Metastasis through Bioinformatic and Experimental Analyses
(913)
HWZ Khella, NMA White, H Faragalla, M Gabril, M Boazak, D Dorian, B Khalil, TT Bao, MD Pasic, RJ Honey, R Stewart, KT Pace, GA Bjarnason, M Jewett, GM Yousef - Li Ka Shing Knowledge Institute of St. Michael´s Hospital, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; London Health Sciences Centre, London, ON, Canada; St. Michael´s Hospital, Toronto, ON, Canada; Sunnybrook Odette Cancer Center, Toronto, ON, Canada
Gene Expression Profiling of Clear Cell Papillary Renal Cell Carcinoma
(851)
KE Fisher, Q Yin-Goen, D Alexis, JS Sirintrapun, W Harrison, BR Isett, MR Rossi, CS Moreno, AN Young, AO Osunkoya - Emory University School of Medicine, Atlanta; Wake Forest University School of Medicine, Winston-Salem
P53 in Epithelioid Angiomyolipoma: An Immunohistochemistry Study and Gene Mutation Analysis
(803)
Z Bing, Y Yao, T Pasha, JE Tomaszewski, PJ Zhang - Hospital of the University of Pennsylvania, Philadelphia; University of Buffalo, Buffalo
Is Renal Angiomyoadenomatous Tumor (RAT) a New Entity? Clinicopathologic, Immunohistochemical and Molecular Cytogenetic Study of 3 Cases
(993)
I Rodriguez, A Panizo, FJ Queipo, I Amat, MR Mercado, M Gomez, J Pardo - Complejo Hospitalario de Navarra ´A´, Pamplona, Spain; ClÍnica Universidad de Navarra, Pamplona, Spain
Significance of Hormone Receptor and Ki-67 Labeling Index in Angiomyolipoma: A Clinicopathological and Immunohistochemical Study of 23 Cases
(915)
M Kim, H-J Lee, M-K Yeo, Y-s Lee, DY Kang - Chungnam National University School of Medicine, Daejeon, Korea
Macrophage Related Markers Expression in MITF/TFE Family Renal Translocation Carcinoma, Melanotic Xp11 Translocation Renal Cancer and Pure Epithelioid PEComa (so Called Epithelioid Angiomyolipoma) of the Kidney
(944)
G Martignoni, D Segala, E Munari, M Pea, S Gobbo, M Brunelli, F Bonetti, C Zampini, C Ghimenton, O Hes, P Camparo, S Pedron, C Pastena, M Chilosi, JN Eble, P Argani - University of Verona, Verona, Italy; Ospedale Orlandi, Bussolengo, Italy; Ospedale Civile Maggiore, Verona, Italy; Charles University and University Hospital, Plzen, Czech Republic; Hopital Foch, Suresnes, Paris, France; Indiana University School of Medicine, Indianapolis, IN; Johns Hopkins Medical Institutions, Baltimore, MD
Unclassified Renal Cell Carcinoma: A Contemporary Study of 116 Cases with Emphasis on Tumors with Aggressive Behavior
(822)
Y Chen, H Al-Ahmadie, A Gopalan, SW Fine, VE Reuter, SK Tickoo - Memorial Sloan-Kettering Cancer Center, New York
Re-Evaluation of TFE3 Immunostaining in UOK 145 Cell Line and a Novel Subtype of PSF-TFE3 Translocation in Xp11 Translocation Renal Cell Carcinoma
(1074)
M Zhong, B Zhu, M Brassesco, M Linehan, M Merino, C Cordon-Cardo, D Zhang, S Rohan, X Yang - Northwestern University, Chicago; University of São Paulo, São Paulo, Brazil; NCI, Bethesda; The Mount Sinai School of Medicine, New York
Should Fuhrman Grading in Clear Cell Renal Cell Carcinomas Be Based on Nucleoli Only?
(813)
SS Chan, L Lee, J Chin, JA Gomez, M Moussa, GM Yousef, MY Gabril - LHSC, London, ON, Canada; St. Michael´s Hospital, Toronto, ON, Canada
Primary Clear Cell Renal Cell Carcinoma and Its Metastasis: A Comparative Analysis of Histologic and Immunophenotypic Features
(863)
EM Genega, VE Brown, B Bahamon, A Ward, L Quintana, S Signoretti - Beth Israel Deaconess Medical Center, Boston, MA; Brigham & Women´s Hospital, Boston, MA
Digital Imaging Tools for Differentiating between Type 1 and Type 2 Papillary Renal Cell Carcinoma
(889)
JA Hipp, JD Hipp, KP Lakshmi, UJ Balis - University of Michigan Health Systems, Ann Arbor, MI
Nuclear and Membranous Smo Expression Is Associated with Low Tumor Grade and Stage in Renal Cell Carcinomas (RCC)
(858)
J Garbaini, K-A Kim, RN Al-Rohil, CE Sheehan, RP Kaufman, JS Ross, A Hayner-Buchan - Albany Medical College, Albany, NY
Differential Gene Expression Profiling in Proliferative Inflammatory Atrophy: A Comparative Molecular Study between PIA, HGPIN and Prostate Cancer
(830)
I de Torres, MT Quiles, C Blazquez, M Arbos, A Navarro, S Ramon y Cajal, J Morote - Hospital Universitari Vall d´ Hebron. Universitat Autonoma de Barcelona, Barcelona, Spain; Institut de Recerca Vall d´Hebron (VHIR), Barcelona, Spain; Hospital Universitari Vall d´ Hebron.., Barcelona, Spain
Integration of Architectural and Cytologic Driven Image Algorithms for Prostate Adenocarcinoma Identification
(890)
JD Hipp, J Monaco, PL Kunju, J Cheng, Y Yagi, J Rodriguez- Canales, MR Emmert-Buck, S Hewitt, MD Feldman, JE Tomaszewski, M Toner, RG Tompkins, T Flotte, D Lucas, JR Gilbertson, A Madabhushi, UJ Balis - University of Michigan, Ann Arbor; Rutgers The State University of New Jersey, Piscataway, NJ; Harvard, Boston; National Cancer Institute, NIH, Bethesda; Perlman School of Medicine at the University of Pennsylvania, Philadelphia; Mayo Clinic, Rochester, MN; Massachusetts General Hospital, Boston, MA
Microvessel Density Correlation with Gleason Score in Prostatic Adencarcinoma – A Computer Assisted Image Analysis in Whole-Mount Prostatecmies
(999)
ME Salama, M Heilbrum, C Dechet, LJ Layfield, T Liu - University of Utah/ARUP, Salt Lake City, UT; University of Utah, Salt Lake City, UT
Insignificant Prostate Cancer: Analysis of Pathobiological Criteria and Predictive Factors
(886)
I Hierro, JE Perez-Enriquez, M Alvarez, C Marchal, L Vicioso, E Gallego, MV Ortega, L Perez-Villa, FJ Machuca, A Matilla - Virgen de la Victoria Hospital, Málaga, Spain
Smaller Prostate Size Is Independently Associated with Biochemical Recurrence in Gleason 7 Prostate Cancer
(864)
B Gershman, F Dong, FJ McGovern, NM Heney, WS McDougal, C-L Wu - Massachusetts General Hospital, Boston, MA
Gleason Score at Surgical Margin Is Not an Independent Predictor of Biochemical Recurrence after Radical Prostatectomy
(970)
S Paluru, V Iremashvili, SA Umar, S Lokeshwar, M Manoharan, R Satyanarayana, MS Soloway, M Jorda - University of Miami , Jackson Memorial Hospital, Miami; University of Miami, Jackson Memorial Hospital, Miami
Standardization of Gleason Grading among 337 Pathologists
(836)
L Egevad, F Algaba, DM Berney, L Boccon-Gibod, E Comperat, AJ Evans, R Grobholz, G Kristiansen, C Langner, A Lopez-Beltran, R Montironi, P Oliveira, B Vainer, M Varma, P Camparo - Karolinska Institutet, Stockholm, Sweden; Fundacio Puigvert- University Autonomous, Barcelona, Spain; St Bartholomew´s Hospital, London, United Kingdom; Hopital Armand Trousseau, Paris, France; Hopital La Pitié-Salpetrière, Paris, France; University of Toronto, Toronto, Canada; Kantonsspital Aarau, Aarau, Switzerland; University Hospital, Bonn, Germany; Medical University, Graz, Austria; Cordoba University Medical School, Cordoba, Spain; Polytechnic University of the Marche Region, Ancona, Italy; Hospital da Luz, Lisboa, Portugal; Rigshospitalet, Copenhagen, Denmark; University Hospital of Wales, Cardiff, United Kingdom; Hopital Foch, Paris, France
Morphologic Features of 184 Gleason Score (GS) 7 Prostate Cancers (PC) with Regional Lymph Node Metastases (LN+) at Radical Prostatectomy (RP)
(926)
ON Kryvenko, N Gupta, D Schultz, J Gomez, N Virani, Z Lane, JI Epstein - Henry Ford Hospital, Detroit; University of Michigan, Ann Arbor; The Johns Hopkins Hospital, Baltimore
Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in South-American Men
(800)
A Billis, L Meirelles, LLLL Freitas, AA Tavares, FF Carvalho, JPU Fontenele, LGF Cortes - University of Campinas (Unicamp) School of Medicine, Campinas, SP, Brazil
The Impact of the 2005 Modified Gleason Grading System on the Clinical Outcome of Prostate Cancer
(834)
F Dong, C Wang, AB Farris, S Wu, H Lee, AF Olumi, WS McDougal, RH Young, C-L Wu - Massachusetts General Hospital, Boston, MA
Upgrading/Downgrading of Prostate Cancer from Biopsy to Radical Prosatectomy: Incidence and Predictive Factors
(840)
JI Epstein, B Trock, A Chang - The Johns Hopkins Hospital, Baltimore
Gleason Grading Reproducibility Highlights Problematic Patterns for Differentiating Gleason Grade 3 Versus Gleason Grade 4: Implications for Active Surveillance Patients
(806)
M Bonham, S Hawley, LP Kunju, D Troyer, L Fazili, E Jones, M Nicholas, J McKenney, L True, J Simko - University of California, San Francisco, San Francisco, CA; Stanford University Medical Center, Palo Alto, CA; University of Michigan, Ann Arbor, MI; Eastern Virginia Medical School, Norfolk, VA; University of British Columbia, Vancouver; University of Texas Health Science Center at San Antonio, San Antonio, TX; University of Washington, Seattle
Correlation of Immunohistochemical Expression of Protein- Coding Genes RAD23B, SIM2S, Notch3, BID and FBP with Biochemical Recurrence in Patients Following Radical Prostatectomy for Prostatic Adenocarcinoma
(961)
CS Moreno, S Sannigrahi, J Cheng, W Zhou, JA Petros, TW Gillespie, AO Osunkoya - Emory University School of Medicine, Atlanta
PSA and NKX3.1: A Comparative IHC Study of Sensitivity and Specificity in Prostate Cancer
(1070)
C Yu, D Tacha, R Bremer, T Haas - Biocare Medical, Concord, CA; Mercy Health Sytems, Janesville, WI
Characterization of Reactive Stroma in Human Prostate Cancer and Role of Prostate Cancer Stem Cells (PCSCs), Growth Factors, Matrix Metalloproteinases (MMPs) and Steroid Hormone Receptors (SHRs) in Its Pathogenesis
(845)
WJ Favaro, A Billis, L Meirelles, LLLL Freitas, LO Reis, U Ferreira - School of Medicine, University of Campinas (Unicamp), Campinas, SP, Brazil; School of Medicine (UNESP), Botucatu, SP, Brazil
Immunohistochemical Expression of MCM2 Predicts Biochemical Recurrence in Prostate Cancer: A Tissue Microarray and Digital Imaging Analysis-Based Study of 428 Cases
(1028)
A Toubaji, S Sutcliffe, A Chaux, K Lecksell, J Hicks, AM De Marzo, EA Platz, GJ Netto - Johns Hopkins University, Baltimore, MD; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Washington University in Saint Louis School of Medicine, Saint Louis, MO; Georgetown University Hospital, Washington, DC
Utilization of Immunohistochemistry in Prostate Needle Biopsies: Quality Assurance and Cost Implications
(1050)
K Watson, C Wang, A Yilmaz, TA Bismar, K Trpkov - Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada
Monoclonal Antibody 6C4 Distinguishes Prostatic Carcinoma from Benign Mimics in Which PIN4 Immunostaining Is Non- Diagnostic
(885)
JF Hechtman, GQ Xiao, Y Kinoshita, PD Unger, DE Burstein - Mount Sinai School of Medicine, New York, NY
E-Cadherin Expression in Prostatic Adenocarcinoma: Correlation with Gleason Score and Comparison with Invasive High Grade Urothelial Carcinoma
(818)
EC Chastain, S Ali, AO Osunkoya - Emory University School of Medicine, Atlanta
button next to any title to add to Itinerary Planner...
Add
